Based on +200
reviews
GW Pharma’s cannabis-based epilepsy drug meets main goal in a late-stage trial
May 6 (Reuters) - GW Pharmaceuticals Plc said on Monday its drug Epidiolex was successful in treating seizures in patients with a rare form of childhood epilepsy called tuberous sclerosis…